Study uses sugar to make and deliver pudding-like brain implants that reduce foreign body response
Brain implants are used to treat neurological dysfunction, and their use for enhancing cognitive abilities is a promising field of research. Implants can be used to monitor brain activity or stimulate parts of the brain using electrical pulses. In epilepsy, for example, brain implants can determine where in the brain seizures are happening.
Brain Canada grant will aid research into neurodevelopmental, psychiatric, and neurodegenerative disorders
Electroencephalography (EEG) is an important tool in understanding the mechanism of brain disorders. Research in the field has gotten a major boost thanks to a $1.85M grant from Brain Canada to support EEGNet, an open repository for EEG data that helps scientists investigate neurodevelopmental, psychiatric, and neurodegenerative disorders.
Comparing two neural maps reveals the roles of genes in cognition, perception and feeling
Many psychiatric disorders have genetic causes, but the exact mechanism of how genes influence higher brain function remains a mystery. A new study provides a map linking the genetic signature of functions across the human brain, a tool that may provide new targets for future treatments.
The Canada Foundation for Innovation supports innovative projects that tackle global challenges
Exciting initiatives involving researchers at The Neuro are among the latest getting support under The Canada Foundation for Innovation’s Innovation Fund competition.
$4.67M from Brain Canada will help probe the brain’s mysteries and create international research links
Research at The Neuro’s McConnell Brain Imaging Centre (BIC) of McGill University will receive a major boost thanks to a $4.67M grant from Brain Canada’s Platform Support Grant (PSG) program.
Program brings together multidisciplinary teams with expertise in various areas of neurodegenerative disease
Neural “signature” may reflect how we respond to feelings of social isolation
Large multi-site study accurately predicts damage to grey matter by disease
An international study has found a link between the brain’s network connections and grey matter atrophy caused by certain types of epilepsy, a major step forward in our understanding of the disease.
Doctor has dedicated his life to improve diagnosis and treatment of neurological diseases and disorders
The Neuro’s director, Dr. Guy Rouleau, is being recognized with Canada’s highest civilian honour, the Order of Canada, for his outstanding contributions as a clinician-scientist and as a leader in health care.
Brain Canada program supports paradigm-shifting neuroscience that improves the lives of Canadians
Four researchers at The Neuro — Boris Bernhardt, Yasser Iturria-Medina, Jean-Francois Poulin, and Jo Anne Stratton — have received grants to support their work in the early-career stage, after being chosen from 150 talented applicants.
Work will tell us how loneliness interacts with brain structure and function in normal aging and pre-symptomatic Alzheimer’s disease
Study identifies rapidly dividing cancer stem cells that can respond to new therapies
Brain cancers have long been thought of as being resistant to treatments because of the presence of multiple types of cancer cells within each tumor. A new study uncovers a cancer cell hierarchy that originates from a single cancer cell type, which can be targeted to slow cancer growth.
C. L. de Carvalho-Heineken Prize recognizes his seminal work in the cognition of music
Cognitive neuroscientist Robert Zatorre has been awarded the C.L. de Carvalho-Heineken Prize in Cognitive Sciences.
Award recognizes his collaborative work in neuroscience and neuroinformatics
Neuroscientist Alan Evans has been awarded the Killam Prize, one of Canada’s highest honours, for his numerous contributions to the understanding of the human brain.
Evans is an internationally recognized researcher at The Neuro (Montreal Neurological Institute-Hospital), James McGill Professor in Neurology and Neurosurgery and the Victor Dahdaleh Chair in Neurosciences.
The Neuro proudly supports the Open COVID Pledge, which calls on academic institutions, industry, and other organizations to make their intellectual property available free of charge for use in ending the COVID-19 pandemic and minimizing its impact.